Comparison of a human neuronal model proteome upon Japanese encephalitis or West Nile Virus infection and potential role of mosquito saliva in neuropathogenesis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 09 08 2019
accepted: 18 04 2020
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 31 7 2020
Statut: epublish

Résumé

Neurotropic flavivirus Japanese encephalitis virus (JEV) and West Nile virus (WNV) are amongst the leading causes of encephalitis. Using label-free quantitative proteomics, we identified proteins differentially expressed upon JEV (gp-3, RP9) or WNV (IS98) infection of human neuroblastoma cells. Data are available via ProteomeXchange with identifier PXD016805. Both viruses were associated with the up-regulation of immune response (IFIT1/3/5, ISG15, OAS, STAT1, IRF9) and the down-regulation of SSBP2 and PAM, involved in gene expression and in neuropeptide amidation respectively. Proteins associated to membranes, involved in extracellular matrix organization and collagen metabolism represented major clusters down-regulated by JEV and WNV. Moreover, transcription regulation and mRNA processing clusters were also heavily regulated by both viruses. The proteome of neuroblastoma cells infected by JEV or WNV was significantly modulated in the presence of mosquito saliva, but distinct patterns were associated to each virus. Mosquito saliva favored modulation of proteins associated with gene regulation in JEV infected neuroblastoma cells while modulation of proteins associated with protein maturation, signal transduction and ion transporters was found in WNV infected neuroblastoma cells.

Identifiants

pubmed: 32374750
doi: 10.1371/journal.pone.0232585
pii: PONE-D-19-22706
pmc: PMC7202638
doi:

Substances chimiques

Proteome 0

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0232585

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Bioinformatics. 2014 Sep 1;30(17):2524-6
pubmed: 24794931
Rev Med Virol. 2012 Mar;22(2):69-87
pubmed: 22086854
J Virol. 2008 Sep;82(18):8978-85
pubmed: 18632868
Ann Trop Med Parasitol. 1952 Dec;46(4):311-9
pubmed: 13008362
PLoS One. 2014 Mar 05;9(3):e90211
pubmed: 24599148
Viruses. 2014 Jul 18;6(7):2796-825
pubmed: 25046180
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Acta Neuropathol. 2016 Feb;131(2):159-184
pubmed: 26659576
Br J Pharmacol. 2010 Dec;161(7):1566-83
pubmed: 20698853
Vector Borne Zoonotic Dis. 2015 Nov;15(11):709-11
pubmed: 26565775
Curr Opin Virol. 2016 Oct;20:119-128
pubmed: 27792906
Nat Immunol. 2010 Oct;11(10):912-9
pubmed: 20818395
Dev Biol (Basel). 2008;131:73-81
pubmed: 18634468
Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11311-6
pubmed: 12186974
Int J Plant Genomics. 2012;2012:494572
pubmed: 23213324
Annu Rev Virol. 2014 Nov;1(1):71-88
pubmed: 26958715
J Virol. 2012 Jul;86(14):7637-49
pubmed: 22573866
Viruses. 2017 Jan 19;9(1):
pubmed: 28106839
Biomed Res Int. 2014;2014:907852
pubmed: 25302311
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Int Immunopharmacol. 2003 Dec;3(13-14):1883-7
pubmed: 14636837
Viruses. 2013 Aug 16;5(8):2019-42
pubmed: 23959328
J Virol. 2015 Oct 14;90(1):292-9
pubmed: 26468544
J Virol. 2011 Feb;85(4):1517-27
pubmed: 21147918
J Virol. 2014 Jan;88(1):164-75
pubmed: 24131723
Hum Pathol. 2004 Aug;35(8):983-90
pubmed: 15297965
PLoS One. 2007 Nov 14;2(11):e1171
pubmed: 18000543
J Med Entomol. 2000 Mar;37(2):250-8
pubmed: 10730496
Gen Pharmacol. 1998 Nov;31(5):655-9
pubmed: 9809459
J Proteome Res. 2015 Dec 4;14(12):5157-68
pubmed: 26485063
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
J Proteome Res. 2013 Jun 7;12(6):2666-78
pubmed: 23647205
Viral Immunol. 2006 Spring;19(1):74-82
pubmed: 16553552
Trans R Soc Trop Med Hyg. 2008 May;102(5):400-8
pubmed: 18342898
Nat Rev Microbiol. 2005 Jan;3(1):13-22
pubmed: 15608696
PLoS Negl Trop Dis. 2017 Jan 13;11(1):e0005294
pubmed: 28085881
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Mol Cell Proteomics. 2009 Jul;8(7):1623-37
pubmed: 19395707
Virology. 2004 Jul 1;324(2):286-96
pubmed: 15207616
PLoS One. 2013 Jul 10;8(7):e68318
pubmed: 23874584
Curr Opin Virol. 2015 Apr;11:44-54
pubmed: 25681709
Virology. 2016 May;492:53-65
pubmed: 26896935
Virol J. 2009 Mar 25;6:35
pubmed: 19320997
Immunol Cell Biol. 2003 Jun;81(3):196-206
pubmed: 12752684
PLoS One. 2012;7(12):e50464
pubmed: 23272060
Antiviral Res. 2010 Sep;87(3):281-94
pubmed: 20452379
Immunity. 2016 Jun 21;44(6):1455-69
pubmed: 27332734
mBio. 2014 Mar 11;5(2):e00902-14
pubmed: 24618253
Trans R Soc Trop Med Hyg. 2006 Dec;100(12):1135-45
pubmed: 16814333
Lancet. 2001 Jul 28;358(9278):261-4
pubmed: 11498211
Oncogene. 2005 Apr 14;24(16):2625-34
pubmed: 15782145
Curr Opin Virol. 2016 Dec;21:139-145
pubmed: 27770704

Auteurs

Benoit Besson (B)

Institut Pasteur, Environment and Infectious Risks Unit, Arbovirus Group, Paris, France.

Justine Basset (J)

Institut Pasteur, Environment and Infectious Risks Unit, Arbovirus Group, Paris, France.

Sandrine Gatellier (S)

Institut Pasteur, Environment and Infectious Risks Unit, Arbovirus Group, Paris, France.

Hélène Chabrolles (H)

Institut Pasteur, Environment and Infectious Risks Unit, Arbovirus Group, Paris, France.

Thibault Chaze (T)

Institut Pasteur, Plateforme Protéomique, Unité de Spectrométrie de Masse pour la Biologie (MSBio), Centre de Ressources et Recherches Technologiques (C2RT), USR CNRS, Paris, France.

Véronique Hourdel (V)

Institut Pasteur, Environment and Infectious Risks Unit, Arbovirus Group, Paris, France.
Institut Pasteur, Plateforme Protéomique, Unité de Spectrométrie de Masse pour la Biologie (MSBio), Centre de Ressources et Recherches Technologiques (C2RT), USR CNRS, Paris, France.

Mariette Matondo (M)

Institut Pasteur, Plateforme Protéomique, Unité de Spectrométrie de Masse pour la Biologie (MSBio), Centre de Ressources et Recherches Technologiques (C2RT), USR CNRS, Paris, France.

Nathalie Pardigon (N)

Institut Pasteur, Environment and Infectious Risks Unit, Arbovirus Group, Paris, France.

Valérie Choumet (V)

Institut Pasteur, Environment and Infectious Risks Unit, Arbovirus Group, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH